MedPath

Intradialytic Inspiratory Muscle Training at Different Intensities and Functional Capacity

Not Applicable
Not yet recruiting
Conditions
Kidney Failure, Chronic
Interventions
Device: Inspiratory Muscle Training
Registration Number
NCT04660383
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

Investigate the effects of Inspiratory Muscle Training (IMT) performed during hemodialysis (HD) procedures in patients with end stage kidney disease (ESKD). With intervention of thirty-six IMT sessions, performed three times a week, at an intensity of 50%, 30% and 10% (sham) of the maximum inspiratory pressure (MIP).

Detailed Description

Introduction: Chronic kidney disease (CKD), especially in its final stage (ESKD), is associated with an increased risk of cardiovascular complications and mortality. Part of this risk can be attributed to the fact that patients with ESKD adopt sedentary behavior.

Objectives: To investigate the effects of Inspiratory Muscle Training (IMT) performed during hemodialysis (HD) procedures in patients with ESKD.

Methodology: Randomized double-blind clinical trial, controlled by sham. Location: Nephrology Sector, Hospital de Clínicas de Porto Alegre (HCPA) Participants: three groups of 12 patients with ESKD on HD randomized to three IMT intensities.

Intervention: Thirty-six IMT sessions, performed three times a week, at an intensity of 50%, 30% and 10% (sham) of the maximum inspiratory pressure (Pimax).

Main outcomes: Functional capacity, diaphragm hypertrophy, respiratory muscle strength, lung volume, blood pressure and quality of life.

Statistical Analysis: Presentation of data in absolute and relative numbers, and through means and standard deviations. To compare the groups, ANOVA will be used, with significance less than 0.05.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria
  • CKD patients who have been on HD for at least three months;
  • In physical conditions to perform the tests proposed by the study;
  • With stable CKD for at least 30 days (with no hospitalization);
Exclusion Criteria
  • Patients with a recent history of arrhythmias;
  • Recent hospitalization (<3 months);
  • Recent acute myocardial infarction (<6 weeks);
  • HD routine less than 2X / week;
  • Muscle or respiratory changes (eg, chronic obstructive pulmonary disease (COPD));
  • Unstable angina;
  • Severe valve disease;
  • Uncontrolled hypertension;
  • Hemoglobin concentration <10 g / dL;
  • Participation in a study with intradialytic exercise in the six months preceding this study;
  • Refusal to participate in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IMT 30Inspiratory Muscle TrainingIMT intervention: IMT30 - 30% of the maximum inspiratory pressure, using equipment "Threshold IMT®" or "Power Breathe®", which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.
IMT 10Inspiratory Muscle TrainingIMT intervention: IMT10 - 10% of the maximum inspiratory pressure, using equipment "Threshold IMT®" or "Power Breathe®", which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.
IMT 50Inspiratory Muscle TrainingIMT intervention: IMT50 - 50% of the maximum inspiratory pressure (MIP), using equipment "Threshold IMT®" or "Power Breathe®", which are respiratory incentives of linear pressure load, where the patient uses a nose clip and breathes through a mouthpiece with a resistance in the inspiratory branch, using the respective MIPs.
Primary Outcome Measures
NameTimeMethod
Change in Functional Capacity (6MWT)Baseline, 3 months

The 6MWT is a useful, validated, and well-tolerated tool that requires no specialized equipment, used to determine the functional capacity of individuals with chronic kidney disease. 19 In addition, the 6MWT is able to represent the submaximal level of functional capacity (e.g., daily physical activity). The results will be defined as the difference in meters in distance covered at weeks 0 and 12. Participants will be instructed to walk on a flat, straight corridor, and will be told that the objective of the test is to walk as far as possible for six minutes at a self-selected speed.

Change in Functional Capacity (CPET)Baseline, 3 months

Patients will be submitted to CPET on an exercise bike, using an incremental loading protocol according to the guidelines published by the American Thoracic Society / American College of Chest Physicians.

Change in diaphragm hypertrophyBaseline, 3 months

Mode B ultrasound (EnVisor C, Philips, Bothell, Washington) with a 12.0 MHz ultrasound probe (L12-3, Philips) will be used for the image of the diaphragm in the apposition zone, the vertical section that rests against the lateral portion of the right rib cage, with the method described by Wait et al.

Secondary Outcome Measures
NameTimeMethod
Change in respiratory muscle strengthBaseline, 3 months

Maximal Inspiratory Measure and Maximal Expiratory Measure: will be carried out by GlobalMed® MVD300 manovacuometry equipment.

Change in ambulatory blood pressure measurement (ABPM)Baseline, 3 months

ABPM is a method that allows indirect and intermittent blood pressure recordings for a period of 24 hours, while patients perform their daily life activities.

Quality of Life assessed by KDQoL Short-FormBaseline, 3 months

Assessed by Kidney Disease Quality of Life Short-Form

Trial Locations

Locations (1)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande Do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath